sandoz Resources | BNET
On MovieTome: SPOILER: Photos from the end of BOND 22!

Resources

26 Resources for

sandoz

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Generics Giant Sandoz Completes $10 Million Expansion in North Carolina, an Industrial Info News Alert
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Dovetailing nicely with the continuing demand for generic drug products, Sandoz has completed a $10 million expansion at its Wilson, North Carolina, Center of Excellence site. The project added 30,000 square feet to the 170,000-square-foot facility. Sandoz is the...
Tags: Sandoz
Research articles 2007-12-28
Research & Markets: With Sales of Over US$4.6 Billion Sandoz is Currently the Second Largest Generic Manufacturer in the World
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36147) has announced the addition of the Espicom Business Intelligence Ltd report: Sandoz Generics Company Intelligence Report to their offering.
Tags: sales, Sandoz
Research articles 2007-05-30
Research and Markets: Gain an Understanding of the Complex Issues Affecting Sandoz the Generics Company
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36147) has announced the addition of the Espicom Business Intelligence Ltd report: Sandoz Generics Company Intelligence Report to their offering.
Tags: Sandoz
Research articles 2006-04-26
340B Prime Vendor Program Adds Sandoz Pharmaceuticals to Growing List of Companies Providing Low-Income Americans With Access to Antibiotic Injectibles and Oral Solid Medications
The 340B Prime Vendor Program, managed by HealthCare Purchasing Partners International® HPPI announced today that it has added global pharmaceutical leader Sandoz a division of Novartis to its growing list of companies providing drugs, supplies and medical devices to clinics, hospitals and health care programs for low-income Americans. HPPI's three-year...
Tags: Microsoft Access, Sandoz
Research articles 2006-04-10
AstraZeneca sells Durascan Medical A/S to Sandoz
NORDIC BUSINESS REPORT-30 June 2004-AstraZeneca sells Durascan Medical A/S to SandozC1994-2004 M2 COMMUNICATIONS LTD http://www.m2.com
Tags: AstraZeneca Plc., Sandoz
Research articles 2004-06-30
Wilson.(EASTERN)
WILSON -- Sandoz, part of Swiss drug maker Novartis, plans to spend $10 million to expand research and development and add 65 jobs here within ... WILSON -- Sandoz, part of Swiss drug maker Novartis, plans to spend $10 million to expand research and development and...
Tags: job, Sandoz
Research articles 2006-07-01
Sandoz Sets Up New Plant In India
Sandoz, the generics division of drug maker Novartis, has invested US$13 million in a third production facility in India. The investment is part of the company's global expansion of production facilities.
Tags: Sandoz
Research articles 2004-05-23
Novartis revives Sandoz brand name. (News: Europe).(Brief Article)
NOVARTIS AG is reviving the name Sandoz as an umbrella brand for its global operations in generic medicines. Since the merger of Sandoz and Ciba-Geigy to form Novartis seven years ago, the 117 year-old Sandoz name has been used on only a...
Tags: brand name, Novartis AG, Sandoz
Research articles 2003-01-27
Common Enterprise Repository For R&D Documents Promises 144% Return on Investment
This article is about the Novartis, The merges of Swiss firms Sandoz and Ciba. It defines the requirements of the merger. Before the merger, employees at Sandoz had relied on a combination of paper files, local servers, PCs, and a VMS system to store their research documentation. The...
Tags: ROI, Novartis AG, R&D, Merger, Finance, Business Operations, Research & Development, Mergers & Acquisitions, Documentum, Sandoz, Investment
White papers 2003-01-01
Sandoz gets precedent-setting US approval for Omnitrope(R) as first follow-on version of a previously approved recombinant biotechnology drug
-- US approval a breakthrough in goal of making high-quality and cost- effective follow-on biotechnology medicines available for patients -- Omnitrope now approved for treatment of growth disorders in children and adults in the US, the European Union and...
Tags: biotechnology, Sandoz
Research articles 2006-05-31
INDIA: SANDOZ SETS UP NEW PLANT IN INDIA.
Sandoz, the generics division of drug maker Novartis, has invested US$13 million in a third production facility in India. The investment is part of the company's global expansion of production facilities. The new unit will ... Sandoz, the generics division of drug maker Novartis, has...
Tags: production facility, Sandoz
Research articles 2004-05-23
Savient Pharmaceuticals Announces Appellate Court Decision in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
US Court of Appeals for the Federal Circuit Temporarily Enjoins Launch of Generic Oxandrolone
Tags: Sandoz
Research articles 2006-12-12
Savient Pharmaceuticals Announces Modification of Temporary Restraining Order in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the U.S. District Court for the District of New Jersey, after considering legal briefs and supporting affidavits from all parties, ordered late on Friday that the temporary restraints contained in the Temporary Restraining Order ("TRO") previously issued by...
Tags: patent, pharmaceutical company, Sandoz
Research articles 2006-12-11
Research and Markets: Novartis and Sandoz Eyeing the Lucrative Erythropoietin Market
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c21659) has announced the addition of Erythropoietin Current Market Dynamics & Future Outlook to their offering.
Tags: Novartis AG, Sandoz
Research articles 2005-07-29
The behemoth from Basle: drug mergers. (the merger of Swiss drug companies Sandoz and Ciba-Geigy will create Novartis, the world's second-largest drug company)(Brief Article)
HOW do you create a world-class drugs company? Merge two medium-sized ones, sack 10,000 people and give the new entity the sort of name you would expect to find on a Japanese car. That, on the face of it, is what Switzerland's Sandoz and Ciba-Geigy areHOW do...
Tags: merger, Novartis AG, Sandoz
Research articles 1996-03-09
Research & Markets: The Sandoz Generics Division is Still the Principal Driver of Growth for Novartis
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44741) has announced the addition of Corporate Focus Healthcare: Novartis Q3 2006 to their offering.
Tags: Novartis AG, Sandoz
Research articles 2006-11-07
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Announces Distribution Agreement with Watson Pharmaceuticals for Authorized Generic of Oxandrin([R])
Tags: pharmaceutical company, Sandoz
Research articles 2006-12-04
SangStat's CYCLOSPORINE Is Bioequivalent to Sandoz' Newest Cyclosporine Formulation, Neoral; Neoral Has Become The Most Commonly Used Formulation Of Cyclosporine In Transplantation
MENLO PARK, Calif.--BUSINESS WIRE--January 6, 1997--SangStat, The Transplant Company (Nasdaq: SANG), announced today that its proprietary formulation of CYCLOSPORINE is bioequivalent to Sandoz' newest cyclosporine formulation, Neoral, in its pivotal bioequivalence trial. The Company filed an application for market clearance of its Neoral-bioequivalent CYCLOSPORINE with the U.S. Food and...
Tags: formulation, Sandoz
Research articles 1997-01-06
Unigene and Novartis Complete Technology Transfer For Calcitonin Manufacturing; Sandoz Successfully Concludes First Full-Scale Production Campaign
FAIRFIELD, N.J. -- The transfer of Unigene Laboratories, Inc. (OTCBB: UGNE) proprietary manufacturing technology to Novartis for manufacturing calcitonin has been completed successfully.
Tags: Novartis AG, Sandoz
Research articles 2005-08-22
Sandoz Nutrition: a healthy approach to R&D. (Sandoz Nutrition Corp.)
Sandoz Nutrition Corp. recognizes the importance of its R&D activities. Its R&D staff faces a productivity standard that aims for a minimum of 30% of company sales from new products developed within the past three years. Sandoz has been improving Sandoz Nutrition Corp. recognizes the importance of its R&D activities....
Tags: nutrition, R&D, Sandoz
Research articles 1995-02-01
advertisement
advertisement